House File 105 (HF 105) is a bill introduced in the Iowa General Assembly that aims to expand the definition of 'medical cannabidiol' under Iowa law. The bill specifies that medical cannabidiol includes various forms of cannabis products, such as oral forms (tablets, capsules, liquids, tinctures, sublingual forms), topical forms (gels, ointments, creams, lotions, transdermal patches), and inhaled forms (nebulizable inhaled forms, vaporizable dried raw cannabis, other vaporizable forms of cannabis). The bill was introduced by Representative Hans Wilz and, after committee approval, was renumbered as HF 950.
Supporters of HF 105 argue that expanding the definition of medical cannabidiol to include a broader range of cannabis products will provide patients with more options for treatment, potentially improving therapeutic outcomes. They believe that allowing various forms of administration can cater to individual patient needs and preferences, enhancing the effectiveness of medical cannabis programs in Iowa.
Critics of HF 105 express concerns that broadening the definition of medical cannabidiol to include inhaled forms, such as vaporizable dried raw cannabis, could lead to increased recreational use and potential abuse. They worry that this expansion might undermine existing regulations and pose challenges in controlling the distribution and consumption of cannabis products within the state.
About This Analysis
This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Iowa General Assembly. Conflict-of-interest analysis for this bill is coming soon.
IA HF105